Literature DB >> 28283271

Multiple chemical sensitivity: Genotypic characterization, nutritional status and quality of life in 52 patients.

Viviana Loria-Kohen1, Helena Marcos-Pasero2, Rocío de la Iglesia2, Elena Aguilar-Aguilar2, Isabel Espinosa-Salinas2, Jesús Herranz2, Ana Ramírez de Molina2, Guillermo Reglero3.   

Abstract

BACKGROUND AND OBJECTIVES: Multiple chemical sensitivity (MCS) is a chronic, multisystem syndrome of unknown etiology. The aim of the present study was to describe the nutritional status and quality of life of patients suffering from MCS, as well as to identify potential polymorphisms associated with this illness. PATIENTS AND METHODS: A cross-sectional, descriptive study was performed on patients with a diagnosis of MCS. Data on anthropometric and body composition variables, hand muscle strength and quality of life were collected. The selection of single nucleotide polymorphisms (SNPs) was based on genes previously associated with MCS and genes involved in inflammatory and oxidative stress pathways.
RESULTS: A total of 52 patients (93.2% female), with a mean age of 50.9 (10.3) years were included in the study. Among them, based on their BMI, 48% had an inadequate nutritional status (17% were underweight and 32% were overweight or obese). Thirty percent of patients had a low muscle mass for their age, 84% had muscle strength below the tenth percentile, and 51.8% had a high fat mass percentage. Regarding quality of life, all median scores were lower than those of other illnesses assessed for every subscale assessed. Statistically significant differences between patient cases and controls were found with respect to rs1801133 (MTHFR), rs174546 (FADS1) and rs1801282 (PPARγ) polymorphisms.
CONCLUSION: A high percentage of patients had a poor nutritional status, low muscle strength and decreased muscle mass. These facts exacerbate the already-lower quality of life of these patients. Specific genetic polymorphisms associated with the syndrome or its pathogenesis were not identified.
Copyright © 2017 Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Calidad de vida; Genetic polymorphisms; Malnutrición; Malnutrition; Multiple chemical sensitivity; Polimorfismos genéticos; Quality of life; Sensibilidad química múltiple

Mesh:

Substances:

Year:  2017        PMID: 28283271     DOI: 10.1016/j.medcli.2017.01.022

Source DB:  PubMed          Journal:  Med Clin (Barc)        ISSN: 0025-7753            Impact factor:   1.725


  5 in total

1.  Repeated pulmonary exposures to zinc ions enhance inflammatory responses to subsequent metal exposures.

Authors:  Christa Watson-Wright; Priscila Queiroz; Sylvia Rodrigues; Thomas C Donaghey; Joseph D Brain; Ramon M Molina
Journal:  Exp Lung Res       Date:  2018-10-08       Impact factor: 2.459

2.  Physiological Health and Physical Performance in Multiple Chemical Sensitivity-Described in the General Population.

Authors:  Anne A Bjerregaard; Marie W Petersen; Sine Skovbjerg; Lise K Gormsen; José G Cedeño-Laurent; Torben Jørgensen; Allan Linneberg; Thomas Meinertz Dantoft
Journal:  Int J Environ Res Public Health       Date:  2022-07-25       Impact factor: 4.614

3.  Background factors of chemical intolerance and parent-child relationships.

Authors:  Kenichi Azuma; Masayuki Ohyama; Emiko Azuma; Takae Nakajima
Journal:  Environ Health Prev Med       Date:  2018-10-24       Impact factor: 3.674

4.  The SNP rs2298383 Reduces ADORA2A Gene Transcription and Positively Associates with Cytokine Production by Peripheral Blood Mononuclear Cells in Patients with Multiple Chemical Sensitivity.

Authors:  Attilio Cannata; Chiara De Luca; Liudmila G Korkina; Nadia Ferlazzo; Riccardo Ientile; Monica Currò; Giulia Andolina; Daniela Caccamo
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

5.  Olfactory-Related Quality of Life in Multiple Chemical Sensitivity: A Genetic-Acquired Factors Model.

Authors:  Alessandro Micarelli; Andrea Cormano; Daniela Caccamo; Marco Alessandrini
Journal:  Int J Mol Sci       Date:  2019-12-25       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.